Buy Generic Medicine Online On India’s No 1 Online Pharmacy

Many patients are unaware that generic medicines contain the same active ingredients as branded drugs and are equally effective. Most people worry about the quality and effectiveness of generic medicines because generic drugs are not as costly as compared to branded drugs. But the quality of the generic drugs is never compromised.These are cost-effective only as research and development, and drug discovery costs are not involved in the case of generic drugs.

• Large multinational pharmaceutical companies held a complete monopoly on the vaccine and ensured that the price of the drug was high.
• It is my ambition that along with being the world leader in generic medicines, we should also promote Indian systems of Medicine.
• With the health sector being a priority, the Government of India is continuously working to provide affordable treatments and medicines at cheaper prices to its citizens.
• Under the scheme, dedicated outlets known as Janaushadhi Kendras are opened to provide generic medicines at affordable prices.
• He asked for a constant coordination between government and Industry to remove disconnect between demand and supply of skilled manpower in pharmacy sector.

We Have 5+ Year’s Experience in exporting medicine globally

There are more than 700 medicines; more than 150 surgicals and consumables are available at affordable prices for all at more than 4000 ‘Jan Aushadi Kedras’ across the nation. ‘Pharma Jan Samadhan’, a customer grievances redressal system was launched and a mobile application – ‘Pharma Sahi Daam’ that provides real-time information to consumers on prices of Scheduled/Non-scheduled medicines has also been introduced. Our medications are sourced from Indian certified manufacturers and meet global regulatory standards. We help you to access high quality generic medicine and overcome financial barriers. How the law works is borne out of the patent decision in 2005 which rejected the Swiss pharmaceutical company Novartis’ attempt to patent the salt/crystalline form of ‘Imatinib,’ a life saving medicine for treating chronic myeloid leukemia.

How are generic medicines different from branded medicines?

It can depend on the clinical data presented by the innovator’s company for the safety profile of the medicine. By offering affordable and accessible healthcare options, generic medicines play a critical role in lowering healthcare costs while ensuring high standards of safety and effectiveness. This law fostered the growth of a strong domestic pharmaceutical industry focused on producing affordable generic drugs. It enabled Indian companies to manufacture medicines at much lower costs, without infringing on patents held by multinational corporations. Before the 1970s, India’s pharmaceutical market was dominated by multinational corporations, which produced and sold branded medicines at high prices. The Indian pharmaceutical industry was relatively underdeveloped, and most medicines, especially life-saving ones, were imported, making them inaccessible to a large part of the population due to high costs.

Challenges Faced by Generic Medicines in India or Problems with Generic Drugs in India

Regarding non-communicable diseases (NCDs), he outlined considerable progress in the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke. The government provides free or highly subsidised treatment for NCDs at public hospitals, with major diseases covered under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PMJAY). The scheme, benefiting approximately 55 crore people, offers US$ 5,886 (Rs. 5 lakh) annual health cover for secondary and tertiary hospitalisation. Additionally, the scheme has extended coverage to senior citizens aged 70 and above. As of November 30, 2024, 218 AMRIT pharmacies operate across 29 states and Union Territories, offering discounted medicines and surgical items.

Pradhan Mantri Jan Aushadhi Yojana: A Game Changer for Generic Medicines

The Vice President of India, Shri M. Venkaiah Naidu has called up on the pharmaceutical industry to work towards making India an International Capital of Generic Medicines. With years of experience and partnerships across the pharmaceutical industry, we guarantee timely and secure delivery. We provide a wide range of specialty drugs, from anti-viral treatments to nephrology drugs, addressing complex medical needs.

What healthcare information does Medkart Pharmacy provide?

Such patents are routinely granted in the US and other countries, but India chose to prioritise access to medicines over the business interests of the pharmaceutical industry. Yes, generic medicines are available for a wide range of diseases, including chronic conditions like diabetes, hypertension, and infectious diseases. Branded drugs are developed after years of research and clinical trials, making the original manufacturer the exclusive seller for a specific time through a patent.

Medicines for Kidney Problems

The recombinant Hepatitis B vaccine is an excellent example of one of India’s low-cost medicines. Large multinational pharmaceutical companies held a complete monopoly on the vaccine and ensured that the price of the drug was high. At $23 per dose, a manufacturer in India saw an unmet need and, in the absence of patent barriers, developed a Hepatitis B vaccine to reduce the price of the drug to less than $1 per dose. Today, India is a main supplier of vaccines to UNICEF and to the Ministries of Health in numerous countries. With an objective of making quality generic medicines available at affordable prices to all, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers in the year 2008.

Find Government Services Faster

Pradhan Mantri Bhartiya Janaushadhi Kendra scheme ensures quality generic medicines available at affordable prices to all citizens. Under the scheme, dedicated outlets known as Janaushadhi Kendras are opened to provide generic medicines at affordable prices. By providing affordable medication options, generic medicines ensure that low-income individuals and underserved populations have access to necessary treatments, reducing healthcare disparities across the country. Generic medicines are produced after the patent on a branded drug expires, allowing multiple manufacturers to make the same drug.

Are generic medicines safe and effective?

With the vision to provide quality generic medicines to all citizens, the government’s Pradhan Mantri Bhartiya Janaushadhi Pariyojana brings this concept to reality. Out of Pocket expenditure on medicines constitutes more than 50% of healthcare expenditure in India. The poor are most affected as branded medicines are expensive and treatments involving the use of such medicines pushes them further into poverty.

• Under the Scheme, dedicated outlets known as Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) are opened to provide generic medicines at cheaper rates to the citizens.
• They help reduce overall healthcare costs, promote health equity, and support government initiatives like the Pradhan Mantri Jan Aushadhi Yojana (PMJAY).
• To ensure high quality, medicines are procured from WHO Good manufacturing practice (GMP), Current Good Manufacturing Practice and CPSUs manufacturers for supplying to Pradhan Mantri Bhartiya Janaushadhi Kendras.
• Along with no compromise on quality, it is also cost-effective, as the cost of research and development and drug discovery is not included in the case of generic drugs.
• The National Institute of Pharmaceutical Education and Research (NIPER) imparts quality education in the areas of pharmaceutical sciences.

How do generic medicines support government healthcare initiatives in India?

It is a common tactic by which the pharmaceutical industry extends their monopoly on drugs beyond the original patent’s 20 years. Long monopoly of a single company in the US  keeps ribociclib price uk prices high because generic competition is blocked. This problem gets further aggravated as almost 80% of expenditure on health care is borne by the patients themselves.

• It is run in a Campaign Mission Mode on the principle of Not for Profits but with Minimal Profits.
• This public health approach to setting strict patent standards is in line with international trade rules and encourages timely entry of affordable generics into the market, driving prices down.
• With rising healthcare costs, the availability of generic drugs has provided relief to patients by offering low-cost alternatives without compromising on quality.
• By providing affordable medication options, generic medicines ensure that low-income individuals and underserved populations have access to necessary treatments, reducing healthcare disparities across the country.
• Quality medicines at affordable prices are now available to the poor and disadvantaged through the “Pradhan Mantri Bhartiya Jan aushadhi Kendras”.
• ‘Pharma Jan Samadhan’, a customer grievances redressal system was launched and a mobile application – ‘Pharma Sahi Daam’ that provides real-time information to consumers on prices of Scheduled/Non-scheduled medicines has also been introduced.
• This law fostered the growth of a strong domestic pharmaceutical industry focused on producing affordable generic drugs.

Search a Government Service

A major turning point came in 2005 when India amended its patent laws to comply with the World Trade Organization’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. The amendment reintroduced product patents for medicines, but India included provisions such as compulsory licensing, which allowed the production of generics for life-saving drugs in cases of public health emergencies. Due to the ability of the Indian pharma companies to produce drugs at economical rates, the cost of HIV/AIDS treatment has gone down to $400 per year from $12,000 – a spectacular contribution to global healthcare. For the benefit of the Indian population, DR BEST Pharmaceuticals also took a great initiative by starting their online pharmacy, which offers generic medicines with up to 80% discount at your doorsteps. The law was designed with the objective of stopping drug giants from indulging in ‘evergreening,’ an unfortunately common and abusive patenting practice in the pharmaceutical industry. It is aimed at filing and then obtaining separate patents – referred to as ‘secondary patents’ – relating to different aspects of the same medicine.

Apply for Pradhan Mantri Bhartiya Janaushadhi Kendra

It is quite heartening to note that the Pharma sector is out-performing most other sectors in achieving consistently high growth. The Pharma industry has posted a robust,  double-digit growth over the last few years. The industry was worth US $36.7 Billion in 2017 and is projected to grow to US $55 Billion by 2020. The Atharva veda is a treasure trove of knowledge and wisdom in the field of medicine. It is clear that since the ancient times India had a very systematic, scientific and rational approach to the treatment of diseases. I have been buying prostate cancer medicine Abiraterone for my dad regularly with them.

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

There is immense scope for technology, innovation and research in pharmaceuticals. Generic drugs export has been growing at a very impressive rate of around 24% per year for the last four years. Our extensive catalog includes specialized drugs that cater to serious conditions such as HIV, Hepatitis, Cancer, and more. We deliver medications worldwide, ensuring that patients from all corners of the globe receive the care they need.

• While the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) has promoted the use of generic medicines, there is still a lack of awareness about the benefits of generics among the general public and even some healthcare professionals.
• Additionally, the scheme has extended coverage to senior citizens aged 70 and above.
• With the health sector being a priority, the Government of India is continuously working to provide affordable treatments and medicines at cheaper prices to its citizens.
• These companies began to challenge the dominance of global pharmaceutical giants by offering the same medicines at significantly reduced prices.
• Long monopoly of a single company in the US  keeps prices high because generic competition is blocked.
• Generic drugs are tested rigorously to ensure they meet the same safety and efficacy standards as brand-name drugs.
• The Jan Aushadhi initiative will make available quality drugs at affordable prices through dedicated stores selling generic medicines which are available at lesser prices but are equivalent in quality and efficacy as expensive branded drugs.

Generic medicines can only be produced after the patent on the brand-name drug has expired. This allows multiple manufacturers to create the same medicine, increasing competition and driving prices down. Generic drugs are tested rigorously to ensure they meet the same safety and efficacy standards as brand-name drugs. FDA (Food and Drug Administration) or India’s CDSCO (Central Drugs Standard Control Organization) ensure that generic drugs adhere to strict guidelines before they are approved for public use. A landmark moment in India’s pharmaceutical history came with the Indian Patents Act of 1970.

Providing Affordable, High-quality Generic Meds Globally

As previously mentioned, generic medicines are far cheaper than branded drugs, allowing patients to afford treatments for chronic conditions like diabetes, hypertension, and cardiovascular diseases without financial strain. “Making quality medicines available at affordable prices has been a key challenge. We will reinvigorate the supply of generic drugs. 3,000 Stores under Prime Minister’s Jan Aushadhi Yojana will be opened during 2017.” This public health approach to setting strict patent standards is in line with international trade rules and encourages timely entry of affordable generics into the market, driving prices down.

Generic Medicines in India: A Revolution in Affordable Healthcare

There is still a large section of the population which finds it difficult to afford these high-priced medicines. According to World Health Organization estimates (2008), 65% of India‟s population does not have access to modern health care. Since 80% of out-patient care and 60% of in-hospital care occurs at private hospitals in India, households are exposed to a private-sector market to buy drugs (Public Health Foundation of India, 2012). According to NSO estimates, upto 79% of health care expenses in rural areas are due to the cost of medicines. Though the government has encouraged the prescription of generic medicines, many doctors in India still prefer prescribing branded drugs due to established relationships with pharmaceutical companies or doubts about the quality of generics. While the Pradhan Mantri Jan Aushadhi Yojana (PMJAY) has promoted the use of generic medicines, there is still a lack of awareness about the benefits of generics among the general public and even some healthcare professionals.